Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 7, 1999

View Archived Issues

Novel echinocandin B tested in neutropenic rabbit model of disseminated candidiasis

In vivo antiangiogenic activity described for FMPA

Company Profile: AtheroGenics

Aurora Biosciences announces two new collaborations with Merck

COX-2 inhibitors: pros and cons debated in current literature

Teva signs letter of intent to acquire Novopharm

Very promising clinical trial results achieved with leukemia treatment

Hollis-Eden reports preliminary results from phase I/II HIV trial in South Africa

Factor Xa inhibitors described by Merck

New series of uroselective alpha1-adrenoceptor antagonists in development at Abbott

Cannabinoids with selectivity for CB2 receptor designed at U.S. university

GABA-A receptor agonists/inverse agonists disclosed by Dainippon

Novel hematinic agent SB-251353 has synergistic effects with G-CSF in preclinical models

Neuroprotective profile of new AMPA/kainate antagonist presented at Neuroscience meeting

Hughes Institute's COBRA compounds target a novel tubulin binding site

Pyridazinone cell adhesion inhibitors investigated as promising antiinflammatory agents

MR-2917: centrally acting muscle relaxant with reduced side effects

Optical resolution of TAN-67; analgesic activity resides in (-)-enantiomer

Gilead terminates U.S. development of adefovir dipivoxil for HIV

News flash: highlights from the AstraZeneca pipeline review

Neuroprotective use-dependent blocker of voltage-dependent Na+ channels, BIII-890-CL

Calpain inhibitor BDA-410 exerts neuroprotective effects in preclinical models

News from ASH: Hemolink performs extremely well in phase II trial in CABG patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026